Chikungunya Vaccine Phase 3 Results Revealed

(Precision Vaccinations) Valneva SE today announces that the Company’s pivotal Phase 3 data for its single-shot chikungunya vaccine candidate, VLA1553, have been published in The Lancet. This article says the strong immune response and the …